Skip to content

Bausch Health Companies BHC Diversified — SG&A

Other segment segments

Bausch + Lomb
$439M-1.8%
Salix
$105M-5.4%
International
$63M+21.2%
Solta Medical
$35M+25.0%

Similar metrics at other companies

DuPont de Nemours, Inc. logo
DDDiversified Industrials — Selling, general and administrative expenses
$116M+9.4%
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — SG&A
$34.69M+12.0%
Moog Inc. logo
MOG.BOther Operating Segment — SG&A
$4.77M+29.1%
Keysight Technologies logo
KEYSTotal segments — SG&A
$371M+32.0%
Agios Pharmaceuticals logo
AGIOReportable Segment — SG&A
$48.3M+16.3%
Moog Inc. logo
MOG.BCorporate Segment and Other Operating Segment — SG&A
$7.76M-9.4%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's diversified — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's diversified — SG&A?
Bausch Health Companies (BHC) reported diversified — SG&A of $43M in Q1 2026.
How has Bausch Health Companies's diversified — SG&A changed year-over-year?
Bausch Health Companies's diversified — SG&A decreased by 4.4% year-over-year, from $45M to $43M.
What is the long-term trend for Bausch Health Companies's diversified — SG&A?
Over 3 years (2022 to 2025), Bausch Health Companies's diversified — SG&A has grown at a -7.1% compound annual growth rate (CAGR), from $211M to $169M.
What does diversified — SG&A mean?
Includes all operating expenses related to the sales, marketing, and general administrative support for the Diversified segment. This metric measures the cost efficiency of the segment's overhead and commercial infrastructure. Monitoring this helps investors evaluate how effectively the company manages its operating costs relative to revenue generation.